Cediranib free base

Cediranib, also known as AZD-2171, is a potent and selective VEGF inhibitor with anti-tumor activity. Cediranib competes with adenosine triphosphate to bind to and inhibit all three vascular endothelial growth factor receptor (VEGF-1,-2,-3) tyrosine kinases, thereby blocking VEGF signaling, angiogenesis, and tumor cell growth.
Supplier Alfa Cytology
Product # BC0017
Pricing 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire
Feedback